4qte
From Proteopedia
(Difference between revisions)
m (Protected "4qte" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | ''' | + | ==Structure of ERK2 in complex with VTX-11e, 4-{2-[(2-CHLORO-4-FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE== |
- | + | <StructureSection load='4qte' size='340' side='right' caption='[[4qte]], [[Resolution|resolution]] 1.50Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[4qte]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QTE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QTE FirstGlance]. <br> | |
- | + | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=390:4-{2-[(2-CHLORO-4-FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE'>390</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene><br> | |
- | + | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qta|4qta]], [[4qtb|4qtb]], [[4qtc|4qtc]], [[4qtd|4qtd]]</td></tr> | |
- | + | <tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase Mitogen-activated protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.24 2.7.11.24] </span></td></tr> | |
+ | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qte FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qte OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qte RCSB], [http://www.ebi.ac.uk/pdbsum/4qte PDBsum]</span></td></tr> | ||
+ | <table> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Mitogen-activated protein kinase]] | ||
+ | [[Category: Arrowsmith, C H.]] | ||
+ | [[Category: Bountra, C.]] | ||
+ | [[Category: Chaikuad, A.]] | ||
+ | [[Category: Delft, F von.]] | ||
+ | [[Category: Edwards, A M.]] | ||
+ | [[Category: Knapp, S.]] | ||
+ | [[Category: SGC, Structural Genomics Consortium.]] | ||
+ | [[Category: Savitsky, P.]] | ||
+ | [[Category: Allosteric]] | ||
+ | [[Category: Inhibitor]] | ||
+ | [[Category: Kinase]] | ||
+ | [[Category: Mapk]] | ||
+ | [[Category: Sgc]] | ||
+ | [[Category: Signalling]] | ||
+ | [[Category: Structural genomic]] | ||
+ | [[Category: Structural genomics consortium]] | ||
+ | [[Category: Transferase]] | ||
+ | [[Category: Transferase-transferase inhibitor complex]] |
Revision as of 08:14, 23 July 2014
Structure of ERK2 in complex with VTX-11e, 4-{2-[(2-CHLORO-4-FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE
|
Categories: Mitogen-activated protein kinase | Arrowsmith, C H. | Bountra, C. | Chaikuad, A. | Delft, F von. | Edwards, A M. | Knapp, S. | SGC, Structural Genomics Consortium. | Savitsky, P. | Allosteric | Inhibitor | Kinase | Mapk | Sgc | Signalling | Structural genomic | Structural genomics consortium | Transferase | Transferase-transferase inhibitor complex